Cpi-818, an Oral Interleukin-2-Inducible T-Cell Kinase Inhibitor, Is Well-Tolerated and Active in Patients with T-Cell Lymphoma

被引：8
|
作者：
Khodadoust, Michael S.
Feldman, Tatyana A.
Yoon, Dok Hyun
Yannakou, Costas K.
Radeski, Dejan
Kim, Youn H.
Mehta-Shah, Neha
Khot, Amit
Wilcox, Ryan A.
Kim, Won Seog
Horwitz, Steven M.
Buggy, Joseph J.
Hotson, Andrew
Hill, Craig M.
Munneke, Brian
Mahabhashyam, Suresh
Miller, Richard A.
Janc, James W.
Mobasher, Mehrdad
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-137782
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] ORAL MANIFESTATIONS OF CUTANEOUS T-CELL LYMPHOMA
    KASHA, EE
    PARKER, CM
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1990, 29 (04) : 275 - 280
  • [42] Discovery of potent inhibitors for interleukin-2-inducible T-cell kinase: structure-based virtual screening and molecular dynamics simulation approaches
    Meganathan, Chandrasekaran
    Sakkiah, Sugunadevi
    Lee, Yuno
    Narayanan, Jayavelu Venkat
    Lee, Keun Woo
    JOURNAL OF MOLECULAR MODELING, 2013, 19 (02) : 715 - 726
  • [43] PRIMARY T-CELL LYMPHOMA OF ORAL CAVITY
    MIKAELIAN, DO
    HARRIS, CL
    SCHERR, SA
    KOSTIANOVSKY, M
    CHIRIFE, AM
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1981, 89 (05) : 742 - 745
  • [44] Romidepsin Is Effective and Well-Tolerated in Patients >= 60 Years Old With Relapsed or Refractory Peripheral T-Cell Lymphoma (PTCL): Analysis From Phase 2 Trials
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2014, 12 (02) : 17 - 18
  • [45] BELINOSTAT IS ACTIVE IN PERIPHERAL T-CELL LYMPHOMA
    O'Connor, O. A.
    Horwitz, S.
    Masszi, T.
    Van Hoof, A.
    Brown, P.
    Doorduijn, J.
    CANCER DISCOVERY, 2015, 5 (08) : 795 - 795
  • [46] Romidepsin Is Effective and Well-Tolerated In Patients ≥ 60 Years Old With Relapsed Or Refractory Peripheral T-Cell Lymphoma (PTCL): Analysis From Phase 2 Trials
    Shustov, Andrei R.
    Coiffier, Bertrand
    Horwitz, Steven M.
    Sokol, Lubomir
    Pro, Barbara
    Nielsen, Tina
    Wolfson, Julie
    Balser, Barbara E.
    Eisch, Robin
    Popplewell, Leslie
    Prince, Miles
    Allen, Steven L.
    Piekarz, Richard
    Bates, Susan E.
    BLOOD, 2013, 122 (21)
  • [47] Population Pharmacokinetics of Romidepsin in Patients with Cutaneous T-Cell Lymphoma and Relapsed Peripheral T-Cell Lymphoma
    Woo, Sukyung
    Gardner, Erin R.
    Chen, Xiaohong
    Ockers, Sandra B.
    Baum, Caitlin E.
    Sissung, Tristan M.
    Price, Douglas K.
    Frye, Robin
    Piekarz, Richard L.
    Bates, Susan E.
    Figg, William D.
    CLINICAL CANCER RESEARCH, 2009, 15 (04) : 1496 - 1503
  • [48] A THEORY OF T-CELL ONTOGENY - INTERLEUKIN-2 AND THE GENERATION OF THE T-CELL REPERTOIRE
    HERBERT, AG
    MARBROOK, J
    WATSON, JD
    IRCS MEDICAL SCIENCE-BIOCHEMISTRY, 1985, 13 (03): : 195 - 199
  • [49] INTERLEUKIN-8 IMMUNOREACTIVITY IN PATIENTS WITH CUTANEOUS T-CELL LYMPHOMA
    MCLEAN, J
    FELICIANI, C
    ROSENTHAL, D
    CHRISTOPHERS, E
    STICHERLING, M
    SCHRODER, JM
    SAUDER, DN
    CLINICAL RESEARCH, 1990, 38 (02): : A686 - A686
  • [50] INTERLEUKIN-8 IMMUNOREACTIVITY IN PATIENTS WITH CUTANEOUS T-CELL LYMPHOMA
    MCLEAN, J
    FELICIANI, C
    ROSENTHAL, D
    CHRISTOPHERS, E
    STICHERLING, M
    SCHRODER, JM
    SAUDER, DN
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1990, 94 (04) : 555 - 555
12345